From: Evaluation of Xpert GBS assay and Xpert GBS LB assay for detection of Streptococcus agalactiae
Author | Year | Country | Study design | Reference standard | Detection method | Sample type | Sample source | The timing of specimen collection | Pregnancy time | The number of sample | TP | FP | FN | TN |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
El Helali | 2009 | French | Prospective | Culturea | Xpert GBS | Vaginal | Hospital | Intrapartum | ≥ 35 weeks | 863 | 135 | 3 | 2 | 723 |
Bourgeois-Nicolaos | 2013 | French | Prospective | Direct cultureb | Xpert GBS | Amniotic fluid | Hospital | Intrapartum | ≥ 37 weeks | 139 | 10 | 2 | 1 | 126 |
Park | 2013 | South Korea | Prospective | Enrichment culturec | Xpert GBS | Vaginal-rectal | Hospital | Antepartum | 35–39 weeks | 175 | 13 | 7 | 2 | 153 |
Buchan | 2014 | America | Prospective | Enrichment culturec | Xpert GBS LB | Vaginal-rectal | Hospital | Antepartum | 35–37 weeks | 826 | 189 | 48 | 2 | 587 |
Buchan | 2014 | America | Prospective | Enrichment culturec | Xpert GBS | Vaginal-rectal | Hospital | Antepartum | 35–37 weeks | 505 | 96 | 15 | 16 | 378 |
Gouve | 2016 | Brazil | Prospective | Enrichment culturec | Xpert GBS | Vaginal-rectal | Hospital | Antepartum | 35–37 weeks | 336 | 55 | 14 | 9 | 258 |
Helmig | 2017 | Denmark | Prospective | Enrichment culturec | Xpert GBS | Vaginal-rectal | Hospital | Intrapartum | ≥ 34 weeks | 105 | 25 | 2 | 0 | 78 |
Rabaan | 2017 | Saudi Arabia | Prospective | Enrichment culturec | Xpert GBS | Vaginal-rectal | Clinics | Antepartum | 35–37 weeks | 554 | 139 | 44 | 0 | 371 |
Plainvert | 2017 | France | Prospective | Direct cultureb | Xpert GBS | Vaginal | Hospitals | Intrapartum | > 34 weeks | 516 | 238 | 56 | 44 | 178 |
Said | 2018 | South Africa | Prospective | Direct cultureb | Xpert GBS | Vaginal-rectal | Hospitals | Antepartum | 26 and 37Â weeks | 279 | 61 | 5 | 9 | 204 |
Shin | 2019 | America | Prospective | Enrichment culturec | Xpert GBS LB | Vaginal-rectal | Hospitals and clinics | Antepartum | 35–37 weeks | 500 | 107 | 40 | 1 | 352 |
Vieira | 2019 | Brazil | Prospective | Direct cultureb | Xpert GBS | Vaginal-rectal | Hospitals | Intrapartum | ≥ 24 weeks | 220 | 21 | 45 | 13 | 141 |
Tickler | 2019 | America | Prospective | Enrichment culturec | Xpert GBS LB | Vaginal or Vaginal/rectal | Hospitals | Unclear | Unclear | 145 | 40 | 0 | 4 | 101 |
Tickler | 2019 | America | Prospective | Enrichment culturec | Xpert GBS LB | Vaginal or Vaginal/rectal | Hospitals | Unclear | Unclear | 210 | 194 | 0 | 16 | 0 |
Tickler | 2019 | America | Prospective | Enrichment culturec | Xpert GBS | Vaginal-rectal | Hospitals | Unclear | Unclear | 100 | 0 | 0 | 0 | 100 |
Tickler | 2019 | America | Prospective | Enrichment culturec | Xpert GBS LB | Vaginal-rectal | Hospitals | Unclear | Unclear | 100 | 0 | 0 | 0 | 100 |
Tickler | 2019 | America | Prospective | Enrichment culturec | Xpert GBS LB | Vaginal-rectal | Hospitals | Unclear | Unclear | 300 | 54 | 17 | 0 | 229 |
Tickler | 2019 | America | Retrospective | Enrichment culturec | Xpert GBS | Vaginal-rectal | Hospitals | Unclear | Unclear | 150 | 149 | 0 | 1 | 0 |
Choera | 2020 | America | Prospective | Enrichment culturec&Revogene GBS LB assay | Xpert GBS LB | Vaginal-rectal | Hospitals | Intrapartum | 35–37 weeks | 250 | 50 | 1 | 1 | 198 |